To establish a quantum dot immunochromatographic test strip for simultaneous detection of central nervous system-specific protein (S100 β) and neuron-specific enolase (NSE), thereby achieving combined detection of both biomarkers.
A double-antibody sandwich immunochromatographic assay was developed using S100β and NSE capture antibodies as the test line and species-specific secondary antibodies as the control line coated on the nitrocellulose membrane. Quantum dot bead-conjugated antibodies targeting S100β and NSE served as fluorescent probes. The preparation parameters of the strip were optimized, and its performance was systematically evaluated to develop a rapid diagnostic strip for mild traumatic brain injury (mTBI). The diagnostic efficacy of the strip was further validated using clinical samples.
The total assay time for combined detection of S100β and NSE was 17 min, with a limit of detection (LOD) of 0.1 ng/mL for S100β and 2.67 ng/mL for NSE. The inter-batch reproducibility of the strips was excellent (coefficient of variation, CV<15%). In clinical validation using 24 mTBI samples, the combined detection strip demonstrated a specificity of 90% and a sensitivity of 92.86%, outperforming single-marker detection. These results prove that the simultaneous quantification of S100β and NSE enhances diagnostic efficacy for mTBI patients.
A combined detection method for the biomarkers S100β and NSE in mTBI, based on quantum dot immunochromatography, has been preliminarily established. This method demonstrates promising clinical application prospects in the auxiliary diagnosis of mTBI.
京公网安备11010802044758号